This provider's $5.3M in total Medicare payments ranks in the 96th percentile of Ophthalmology providers nationally.
Medicare payments to this provider grew 7974% from 2017 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1004% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $534.70 | $80.35 | 6.65x | $454.35 | $15.8K | 189 | 166 |
| 2018 | $603.74 | $115.93 | 5.21x | $487.81 | $48.7K | 536 | 513 |
| 2019 | $1.0K | $230.78 | 4.35x | $772.70 | $537.9K | 6.1K | 2.8K |
| 2020 | $726.52 | $210.32 | 3.45x | $516.20 | $1.1M | 12.1K | 3.3K |
| 2021 | $722.45 | $223.65 | 3.23x | $498.80 | $1.2M | 12.4K | 3.2K |
| 2022 | $728.36 | $216.10 | 3.37x | $512.26 | $1.1M | 12.0K | 2.7K |
| 2023 | $936.45 | $253.15 | 3.70x | $683.30 | $1.3M | 12.9K | 3.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 12.7K | $1.2M | $91.16 | 3.29x |
| 67028 | Injection of drug into eye | 12.4K | $1.0M | $83.55 | 4.01x |
| J0178 | Injection, aflibercept, 1 mg | 1.3K | $942.9K | $713.25 | 2.80x |
| J2778 | Injection, ranibizumab, 0.1 mg | 2.9K | $683.1K | $232.82 | 3.44x |
| J7999 | Compounded drug, not otherwise classified | 6.5K | $440.7K | $67.31 | 1.49x |
| 92134 | Diagnostic imaging of retina | 11.7K | $351.0K | $30.03 | 3.48x |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | 2.3K | $157.0K | $67.89 | 2.96x |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 951 | $99.8K | $104.95 | 2.99x |
| 92250 | Photography of the retina | 2.8K | $88.8K | $31.63 | 5.28x |
| J9035 | Injection, bevacizumab, 10 mg | 1.4K | $87.7K | $62.91 | 1.59x |
| 67041 | Removal of membrane from the retina | 102 | $87.1K | $853.58 | 3.20x |
| 67036 | Removal of eye fluid (vitreous) between the lens and retina | 105 | $23.2K | $221.36 | 6.00x |
| 99284 | Emergency department visit, problem of high severity | 274 | $22.3K | $81.42 | 2.66x |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | 85 | $21.8K | $256.17 | 7.31x |
| 67108 | Repair of detached retina and drainage of eye fluid between lens and retina | 54 | $13.8K | $254.96 | 5.86x |
| 67042 | Removal of membrane from the retina, pars plana approach | 46 | $9.9K | $216.07 | 5.81x |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | 106 | $8.2K | $77.33 | 3.46x |
| 67113 | Repair of detached retina and drainage of eye fluid between lens and retina | 19 | $8.1K | $426.40 | 4.80x |
| 99283 | Emergency department visit, moderately severe problem | 167 | $6.9K | $41.55 | 3.18x |
| 67040 | Laser destruction of eye fluid (vitreous) between the lens and retina | 11 | $4.8K | $432.10 | 5.30x |
This provider submits charges 3.26 times higher than what Medicare actually pays.
A markup ratio of 3.26x means for every $100 Medicare pays, this provider initially charges $326. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Jason Ysasaga, M.D. | Amarillo, TX | $61.5M | ✓ Clear |
| Harshivinderjit Bains, MD | Tyler, TX | $53.9M | ✓ Clear |
| Ryan Rush, MD | Amarillo, TX | $53.6M | ✓ Clear |
| Tien Wong, M.D. | Houston, TX | $51.2M | ✓ Clear |
| Thomas Bochow, M.D., M.P.H. | Tyler, TX | $49.4M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data